| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 60,024 | 49,250 | 40,289 | 42,417 | | Cost of Revenue | 30,901 | 25,053 | 19,357 | 23,472 | | | Gross Profit | 29,123 | 24,197 | 20,932 | 18,945 | | | Operating Expenses | | Research Development | 6,846 | 7,689 | 7,724 | 14,114 | | Selling General and Administrative | 11,209 | 11,519 | 11,903 | 22,809 | | Non Recurring |
-
|
-
|
-
| 1,958 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,068 | 4,989 | 1,305 | (19,936) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 178 | 754 | 824 | 1,845 | | Earnings Before Interest And Taxes | 11,246 | 5,743 | 2,129 | (18,091) | | Interest Expense |
-
|
-
|
-
| 9 | | Income Before Tax | 11,246 | 5,743 | 2,129 | (18,100) | | Income Tax Expense | 2,094 | 1,214 | 1,725 | 2,554 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,152 | 4,529 | 404 | (20,654) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,152 | 4,529 | 404 | (20,654) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,152 | $4,529 | $404 | ($20,654) |
|
0.51% Nasdaq 
Income Statement
